Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo

Our research group demonstrated that riluzole, an inhibitor of glutamatergic signaling reduced melanoma cell proliferation in vitro and tumor progression in vivo. The underlying mechanisms of riluzole are largely unknown. Microarray analyses on two human melanoma cell lines revealed that riluzole st...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Seung-Shick, Jeong, Byeong-Seon, Wall, Brian A., Li, Jiadong, Shan, Naing Lin, Wen, Yu, Goydos, James S., Chen, Suzie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234219/
https://www.ncbi.nlm.nih.gov/pubmed/30425240
http://dx.doi.org/10.1038/s41389-018-0098-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234219/
https://www.ncbi.nlm.nih.gov/pubmed/30425240
http://dx.doi.org/10.1038/s41389-018-0098-7

Ejemplares similares